HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alison Skrinar Selected Research

Muscular Diseases (Myopathy)

1/2019A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy.
1/2018Phenotypic stratification and genotype-phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portion.
1/2017Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model.
1/2016Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study.
4/2010A randomized study of alglucosidase alfa in late-onset Pompe's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alison Skrinar Research Topics

Disease

7Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
01/2022 - 01/2018
7Rickets (Rachitis)
01/2022 - 01/2018
5Pain (Aches)
04/2022 - 01/2018
5Muscular Diseases (Myopathy)
01/2019 - 04/2010
4Congenital Abnormalities (Deformity)
01/2022 - 01/2018
3Hypophosphatemia
01/2022 - 01/2018
3Glycogen Storage Disease Type II (Pompe's Disease)
04/2010 - 04/2007
2Body Weight (Weight, Body)
01/2018 - 04/2010
1Hyperparathyroidism
04/2022
1Nephrocalcinosis
04/2022
1Musculoskeletal Diseases (Musculoskeletal Disease)
01/2022
1Abscess
01/2022
1Fatigue
01/2021
1Wasting Syndrome (Wasting Disease)
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Distal Myopathies (Distal Muscular Dystrophy)
01/2018
1Osteomalacia
01/2018
1Nonaka type Distal myopathy
01/2017

Drug/Important Bio-Agent (IBA)

8Phosphates (Orthophosphate)IBA
01/2022 - 01/2018
7burosumabIBA
01/2022 - 01/2018
6Fibroblast Growth Factor-23IBA
01/2022 - 01/2018
5Phosphorus (Red Phosphorus)IBA
01/2021 - 01/2018
4Monoclonal AntibodiesIBA
01/2022 - 01/2018
4AcidsIBA
01/2019 - 04/2007
4N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2019 - 01/2016
3Vitamin DFDA LinkGeneric
01/2022 - 07/2019
2Alkaline PhosphataseIBA
01/2022 - 01/2021
2EnzymesIBA
01/2017 - 04/2010
2alpha-Glucosidases (Acid Maltase)IBA
04/2010 - 04/2007
2GlycogenIBA
04/2010 - 04/2007
2human GAA protein (Myozyme)FDA Link
04/2010 - 03/2009
1Calcitriol (Calcijex)FDA LinkGeneric
01/2022
1SaltsIBA
01/2022
1CreatinineIBA
01/2019
1PHEX Phosphate Regulating Neutral EndopeptidaseIBA
01/2019

Therapy/Procedure

5Therapeutics
04/2022 - 01/2018
1Parathyroidectomy
04/2022